Brussels, Belgium
September 27, 2002
In a new study
funded by Agricultural
Biotechnology in Europe (ABE) and presented in Brussels
today, Brookes West consultancy reports that small farmers in
North East Spain are achieving environmental benefits as well as
higher yields, better quality and increased income by growing
genetically modified maize (Bt Maize). Bt Maize protects the
crop against attack by the European Corn Borer (ECB), which can
lead to yield losses of 15% or more.
Spanish farmers as
well as other Southern European farmers have suffered from the
ECB for generations. But currently Spain is the only country in
the European Union where GM crops are grown commercially and is
therefore the best European example of the benefits Bt Maize
offers.
Most Spanish farmers
do not use any active form of treatment for dealing with the
pest. This is mainly because the larval damage is hidden, heavy
infestations are unpredictable, checking the fields multiple
times each summer takes time and skill, the difficulty of timing
spraying and the perceived high costs of the treatment.
Genetically modified insect resistant maize provides a new
management tool for all corn producers to increase yields where
ECB is a problem.
The average farm
size in North East Spain is just 50 hectares, with maize only
being grown on part of the area. On average, these small scale
farmers received an increased income of €150 (per hectare)
compared with growing conventional maize. Their enthusiastic
uptake of the GM maize confirms that the benefits of this
technology are not limited to large farmlands, in fact
delivering pest control can benefit all scales of farming.
Graham Brookes,
author of the report, said "Many people don’t realise that GM
crops are being successfully grown in the EU. In this North
Eastern region of Spain, over 20,000 hectares of Bt maize has
been grown every year since 1998". This represents over 4% of
the total Spanish maize crop, and it is estimated that this
would rise to 36% if the Bt trait would be freely available in
all major maize varieties.
Summary of Report
The farm scale impact of using Bt Maize
in Spain
Genetically modified
maize has been successfully grown on a commercial basis in Spain
for several years. A study of farmers’ experience of growing Bt
maize in the Huesca region has recently been undertaken by
Brookes West – a UK consultancy.
Some of the key
conclusions from the report are summarised below:
-
Spain is an
important maize-growing country, accounting for approximately
11% of the total EU crop.
-
In the 2001/2002
growing season, 20,000-25,000 hectares of insect resistant GM
maize (Bt maize) was grown. This is 4-5% of the total Spanish
maize crop. Growing on this scale has taken place since 1998,
but further expansion has been restricted through a voluntary
agreement by the seed supplier (Syngenta).
-
There is no size
barrier to the successful use of the technology: in Spain, Bt
maize is being grown on farms of only 50 hectares on average.
-
The Bt maize grown
in Spain is sold through the usual channels for animal feed
use. The supply chain has not seen a need for segregation, and
normal commodity prices apply. Indeed, grain quality is
perceived to be higher because of the lower levels of
mycotoxins.
-
Given the future
availability of the Bt trait in all leading varieties and the
dropping of voluntary seed supply restrictions, it is
estimated that GM seed would account for 36% of all maize
production in Spain; some 173,000 hectares in total.
-
At this scale of
use, a conservative estimate of the average improvement in
yield (a range of 1.8 to 2.5%) suggests an increased crop of
88,000 to 125,000 tonnes. This would give the farmers an extra
€11 – 15 million in income at current prices.
-
The primary pest
which is controlled in this crop is the European Corn Borer.
Because of the difficulty of timing treatment accurately, Bt
maize is more effective at reducing yield loss than
insecticides used on conventional crops. For the Huesca
region, in areas of high pest pressure, use of Bt maize gives
an average yield increase of 15% where no insecticide was
previously used, and 10% even where the conventional crop had
been sprayed.
-
There is a cost
premium of €18-19 per hectare for the GM seed. This is more
than offset by the increased yield and savings in spraying
costs.
-
In the Huesca
region, the average income rose by nearly €150 per hectare of
maize, representing an increase of 12.9% in the gross margin
for the farmer.
-
For farmers who do
not normally spray to control pests, a yield increase of only
1.5% is necessary to cover the increased cost of seed. Even in
areas of low to medium pest pressure, this is likely to be
exceeded in a significant proportion of crop years.
-
For such low
infestation areas, the use of Bt maize acts as a form of
insurance, offering increased certainty of consistently high
yields. For this reason, some farmers choose to plant Bt maize
even though the impact on profitability may be neutral when
averaged over several years.
The full report can
be accessed at
http://www.europabio.org/pages/ne_gbgmcrops.asp
The author of the report,
Graham Brookes, of Brookes West consultancy, was previously
agricultural economist at the Centre for European Agricultural
Studies at Wye College, University of London.
This report was
funded by Agricultural
Biotechnology in Europe (ABE),
a communications initiative, sponsored by six of Europe’s
leading agricultural biotechnology companies. A condition of
undertaking the research was that the findings would not be
influenced by the members of ABE. Any comments from ABE members
that have been taken into consideration are of a factual basis
only. The report is independent and contains the objective views
of the author based on field interviews and analysis.
The agricultural
biotechnology industry believes that consumers have a right to
know the facts, and that industry has an obligation to inform
them. ABE are therefore working with organizations across Europe
to foster a useful dialogue. ABE undertake wide ranging
communication initiatives with a variety of stakeholders- the
food and feed industries, retailers, media, policy-makers and
others. The aim is to listen to and address the concerns of
Europeans as well as making information available about the
industry and this technology, aimed at providing factual
information to the food and feed chain in Europe, and this
report is the first in a series.
The following companies are
participating in this effort:
- Bayer Crop Science
- BASF
- Bayer
- Dow Agro Sciences
- Monsanto
- Syngenta
EuropaBio has almost 40
corporate members operating worldwide and 19 national
biotechnology associations representing some 1200 SMEs involved
in research and development, testing, manufacturing and
distribution of biotechnology products. EuropaBio, the voice of
European bioindustries, aims to be a promoting force for
biotechnology and to present its proposals to industry,
politicians, regulators, NGOs, and the public at large.
|